Concepedia

N. Savani

NS

Statistics

Publications

4

Citations

141

H-Index

4

Active since

1999

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

N. Savani is an author at GlaxoSmithKline (United Kingdom) specializing in pain medicine, pharmacy, and migraine pharmacology.

Publications per year

1999–2006

4

Publications

4

Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine

Stephen H. Landy, N. Savani, S. D. Shackelford et al. · International Journal of Clinical Practice · 2004 · 75 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Killed <i>Mycobacterium vaccae</i> suspension in children with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial

J. Berth‐Jones, Peter D. Arkwright, Dujomir Marasović et al. · Clinical & Experimental Allergy · 2006 · 35 citations

Medicine, Dermatology, Immunology +14

Switching patients with migraine from sumatriptan to other triptans increases primary care costs

N. Savani, Dominy Browning · International Journal of Clinical Practice · 2004 · 17 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +15

A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.

N. Savani, N. J. Brautaset, Mauri Reunanen et al. · PubMed · 1999 · 14 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

1–4 of 4